Xylem Inc.XYLNYSE
Loading

Analyst Sentiment

Analysts lean bullish — 65% recommend buying.

Consensus Rating
Buy
20 analysts·High coverage
65%
Rating Distribution
Strong Buy
00%
Buy
1365%
Hold
630%
Sell
15%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see moderate upside — consensus target 28% higher.

Bear Case
$138.00
+9%
Consensus
$162.67
+28%
Bull Case
$176.00
+38%
Price Range20 analysts
Low
Consensus
High
$138.00
$176.00
Current Target
Current Price
$127.18
Upside to Target
$35.49

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Feb 13, 2026UBS
Xylem price target lowered to $155 from $168 at UBS
Target:$155.00
+20.9%from $128.21
Feb 12, 2026Oppenheimer
Xylem price target lowered to $165 from $170 at Oppenheimer
Target:$165.00
+29.9%from $127.02
Feb 11, 2026Goldman Sachs
Xylem price target lowered to $158 from $175 at Goldman Sachs
Target:$158.00
+24.6%from $126.77
Feb 11, 2026Mizuho Securities
Xylem price target lowered to $138 from $150 at Mizuho
Target:$138.00
+7.7%from $128.19
Feb 11, 2026Stifel Nicolaus
Xylem price target lowered to $175 from $178 at Stifel
Target:$175.00
+35.7%from $128.92
Feb 11, 2026Robert W. Baird
Xylem price target lowered to $161 from $178 at Baird
Target:$161.00
+24.9%from $128.92
Jan 7, 2026Barclays
Xylem price target lowered to $166 from $172 at Barclays
Target:$166.00
+17.5%from $141.33
Jan 5, 2026Mizuho Securities
Xylem price target lowered to $150 from $160 at Mizuho
Target:$150.00
+9.4%from $137.11
Oct 29, 2025Stifel Nicolaus
Xylem price target raised to $178 from $175 at Stifel
Target:$178.00
+16.0%from $153.43
Oct 29, 2025Argus Research
Xylem price target raised to $170 from $165 at Argus
Target:$170.00
+10.8%from $153.40
Oct 29, 2025Mizuho Securities
Xylem price target raised to $160 from $140 at Mizuho
Target:$160.00
+6.3%from $150.50
Oct 29, 2025RBC Capital
Xylem price target raised to $176 from $169 at RBC Capital
Target:$176.00
+14.7%from $153.48
Oct 29, 2025Robert W. Baird
Xylem price target raised to $178 from $171 at Baird
Target:$178.00
+16.0%from $153.48
Oct 29, 2025Barclays
Xylem price target raised to $172 from $165 at Barclays
Target:$172.00
+14.3%from $150.50
Sep 18, 2025Barclays
Xylem initiated with an Overweight at Barclays
Target:$165.00
+16.1%from $142.18
Aug 5, 2025UBS
Xylem price target raised to $168 from $164 at UBS
Target:$168.00
+17.0%from $143.61
Aug 13, 2024UBS
Xylem initiated with a Buy at UBS
Target:$165.00
+29.4%from $127.50
Jul 31, 2024Robert W. Baird
Xylem price target raised to $170 from $155 at Baird
Target:$170.00
+27.4%from $133.48
May 31, 2024Oppenheimer
Xylem (XYL) PT Raised to $152 at Oppenheimer
Target:$152.00
+9.0%from $139.40
May 29, 2024Argus Research
Xylem (XYL) PT Raised to $165 at Argus
Target:$165.00
+17.6%from $140.36
May 3, 2024Mizuho Securities
Xylem price target raised to $135 from $110 at Mizuho
Target:$135.00
-0.7%from $135.99
May 3, 2024RBC Capital
Xylem (XYL) PT Raised to $162 at RBC Capital
Target:$162.00
+19.1%from $135.99
May 3, 2024Robert W. Baird
Xylem price target raised to $155 from $151 at Baird
Target:$155.00
+14.0%from $135.99
Apr 8, 2024Wolfe Research
Xylem price target raised to $143 from $138 at Wolfe Research
Target:$143.00
+11.5%from $128.27
Apr 4, 2024RBC Capital
Xylem price target raised to $153 from $145 at RBC Capital
Target:$153.00
+20.2%from $127.25